To Evaluate Analgesic Effect of Dexmedetomidine with Ropivacaine in USG Guided Erector Spinae Plane Block for Breast Surgery
Phase 4
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2020/06/025660
- Lead Sponsor
- Department of Anaesthesiology Maharana Bhupal Government Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA Grade I and II
Posted for Modified Radical Mastectomy surgery
Exclusion Criteria
Patient refusal
ASA Grade III and above
Drug allergy
Obese(BMI >35 kg per sq.m)
Bradycardia
Coagulopathy
Cardiac Conduction Block
Infection at Injection site
patient n beta blocker or antiplatelet
Psychiatric illness
Chronic analgesic Use
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of analgesia <br/ ><br>Duration of analgesia <br/ ><br>Timepoint: 24 hour post operatively
- Secondary Outcome Measures
Name Time Method Intra operative hemodynamic <br/ ><br>Adverse effectTimepoint: Intra operatively <br/ ><br>24 hour post operatively